Skip to main content
English
ไทย
Log In
Log in
New user? Click here to register.
Have you forgotten your password?
Communities & Collections
All of Mahidol IR
Mahidol Journals
Statistics
About Us
Customer Feedback
Deposit
Home
Articles from Academic Databases : SCOPUS
Scopus 2020
Publication:
Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series
Issued Date
2020-12-01
Resource Type
Article
ISSN
20500904
DOI
10.1002/ccr3.3407
Other identifier(s)
2-s2.0-85092529177
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Case Reports. Vol.8, No.12 (2020), 3264-3277
Suggested Citation
APA
IEEE
MLA
Chicago
Vancouver
Manoon Surabotsophon, Yingyot Klai-On, Vipa Thanachartwet, Sirote Khunapornphairote, Supat Chamnanchanunt, Theerapat Racharak, Wannada Laisuan, Duangjai Sahassananda, Samlee Hapunna, Somjit Jinapuk, Suthee Leelasetakul, Varunee Desakorn
Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series.
Clinical Case Reports. Vol.8, No.12 (2020), 3264-3277.
doi:10.1002/ccr3.3407
Retrieved from:
https://repository.li.mahidol.ac.th/handle/123456789/60534
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series
Author(s)
Manoon Surabotsophon
Yingyot Klai-On
Vipa Thanachartwet
Sirote Khunapornphairote
Supat Chamnanchanunt
Theerapat Racharak
Wannada Laisuan
Duangjai Sahassananda
Samlee Hapunna
Somjit Jinapuk
Suthee Leelasetakul
Varunee Desakorn
Other Contributor(s)
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Mahidol University
Ramkhamhaeng Hospital
Abstract
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. Three patients diagnosed with severe COVID-19 pneumonia received treatment with hydroxychloroquine combined with lopinavir, ritonavir, and favipiravir. Two patients diagnosed early, received tocilizumab when the pneumonia became severe and survived. The thrid patient was diagnosed late and received tocilizumab when the disease progressed to acute respiratory distress syndrome, and died.
Keyword(s)
Medicine
Availability
URI
https://repository.li.mahidol.ac.th/handle/123456789/60534
Collections
Scopus 2020
Full item page
Send Feedback